Zobrazeno 1 - 10
of 118
pro vyhledávání: '"C Massacesi"'
Autor:
C Massacesi, A Core, M Di Eusanio, G Di Francesco, M Di Saverio, L Marini, M Rolando, G Gregori
Publikováno v:
European Heart Journal Supplements. 25:D151-D152
Acute Coronary Syndrome (ACS) are events due to the rupture/erosion of a coronary atherosclerotic plaque, with activation of the coagulation cascade and critical reduction of the flow, which is expressed in a spectrum of clinical scenario ranging fro
Autor:
C Massacesi, A Core, M Di Eusanio, G Di Francesco, M Di Saverio, L Marini, M Rolando, G Gregori
Publikováno v:
European Heart Journal Supplements. 25:D113-D114
A 96–years–old woman was admitted to our cardiological intensive care unit in December 2022 with atrioventricular dissociation, with a junctional ventricular escape rhythm at a rate of 38 beats per minute, and an atrial rhythm dissociated from th
Autor:
C Massacesi, M Di Saverio, B Iadanza Lanzaro, M Rolando, G Befacchia, A Core, M Di Eusanio, G Di Francesco, L De Berardis, G Gregori, C Napoletano
Publikováno v:
European Heart Journal Supplements. 24
A 52–year–old man arrived at the local emergency room for worsening dyspnea and asthenia, present for about a month, but significantly worsening during the night of the access. The ECG (Figure 1) revealed complete AtrioVentricular Block (ABV) wit
Autor:
M Di Saverio, C Massacesi, M Rolando, B Iadanza Lanzaro, A Marrangoni, G Gregori, C Napoletano, L Marini, A Gennarelli
Publikováno v:
European Heart Journal Supplements. 24
Introduction Left ventricular pseudoaneurysm is a rare complication of myocardial infarction and its natural history is still unclear. Non invasive imaging improves detection ability and differential diagnosis with aneurysm. We present the case of la
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background: In the phase 2 CAMMS223 trial (NCT00050778), alemtuzumab significantly improved clinical and MRI outcomes versus subcutaneous interferon beta-1a over 3 years in treatment-naive patients with relapsing–remitting MS. Here, we assess effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::13e06ded353cf3a43b06663f55e0ec5a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2997434
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2997434
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. Lucenti, Giuseppe Toffoli, Diana Crivellari, Roberto Sorio, Chiara Lestuzzi, Giuseppe Corona, M. D. Magri, C. Massacesi, Davide Lombardi, Andrea Veronesi, R. Talamini
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 17(5)
Background To determine if protracted low-dose oral idarubicin (IDA), feasible in a previous dose-finding study, would result in similar activity and a better toxicity profile in patients with metastatic breast cancer. Patients and methods Elderly wo
Publikováno v:
Journal of experimentalclinical cancer research : CR. 24(1)
We evaluated the efficacy and toxicity profile of single-agent docetaxel administered in daily clinical practice at low-dose regimen in 37 pre-treated elderly patients with metastatic breast cancer previously exposed to chemotherapy. Docetaxel was em